Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today

Investment will bring Canada’s first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies. At project

Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on

December 2, 2020 – MOUNTAIN VIEW, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced that it has received ISO-13485

Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for

PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine PNI offers expertise in self-amplifying mRNA vectors, lipid-based

Madison, WI, USA, October 5, 2020 — Nimble Therapeutics Inc. today announced the company has entered into a strategic collaboration

San Diego, CA – Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that

Salt Lake City, Utah. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL